Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome Symptoms

Trial ID or NCT#

NCT02026063

Status

not recruiting iconNOT RECRUITING

Purpose

The primary objective of this study is to evaluate the long-term safety and tolerability of orally administered telotristat etiprate.

Official Title

A Multicenter, Long-term Extension Study to Further Evaluate the Safety and Tolerability of Telotristat Etiprate (LX1606)

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Show Less

Investigator(s)

George A. Fisher Jr.
George A. Fisher Jr.
Medical oncologist, Gastrointestinal specialist
Colleen Haas Chair in the School of Medicine, Emeritus

Contact us to find out if this trial is right for you.

Contact

CCTO
650-498-7061

View on ClinicalTrials.gov